Balance Sheet
Cash Flow Statement
Growth Metrics
Income Statement
Others
Ratios
Assets AverageDebt RatioDebt to EquityEnterprise ValueEquity AverageEquity RatioInterest Coverage RatioInvested CapitalReturn on AssetsReturn on Capital EmployedReturn on EquityTimes Interest Earned

United Health Products (UEEC) EBITDA Margin (2016 - 2022)

United Health Products' EBITDA Margin history spans 12 years, with the latest figure at 1437.81% for Q3 2022.

  • Quarterly results put EBITDA Margin at 1437.81% for Q3 2022, changed N/A from a year ago — trailing twelve months through Jun 2023 was 6992.46% (changed N/A YoY), and the annual figure for FY2022 was 7472.1%, up 5050207874.0%.
  • EBITDA Margin for Q3 2022 was 1437.81% at United Health Products, up from 45263035.59% in the prior quarter.
  • In the past five years, EBITDA Margin ranged from a high of 1437.81% in Q3 2022 to a low of 45263035.59% in Q1 2021.
  • The 5-year median for EBITDA Margin is 214366.32% (2020), against an average of 6473286.19%.
  • The sharpest move saw EBITDA Margin plummeted -301060bps in 2018, then tumbled 2000000000bps in 2021.
  • Year by year, EBITDA Margin stood at 4433.19% in 2018, then crashed by -177bps to 12265.68% in 2019, then crashed by -45466bps to 5588962.5% in 2020, then tumbled by -710bps to 45263035.59% in 2021, then surged by 100bps to 1437.81% in 2022.
  • According to Business Quant data, EBITDA Margin over the past three periods came in at 1437.81%, 45263035.59%, and 5588962.5% for Q3 2022, Q1 2021, and Q4 2020 respectively.